Alternative way to inhibit STAT3 signaling in gastric cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The biologic impact of janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) axis in gastric cancer has been well established. Phosphorylated STAT3 dimerize and act as a transcription factor to upregulate various target genes involving tumor invasion and epithelial-mesenchymal transition (EMT). Furthermore, JAK2/STAT3 signaling mediates core interaction between cancer cells and microenvironmental immune system. For example, activated STAT3 in gastric epithelial cells by Helicobacter pylori (H. pylori)-induced cytotoxin-associated antigen (CagA) modulates differentiation of Thelper (Th)-17 lineage to promote chronic mucosal inflammation, atrophy and intestinal metaplasia. Thus, inhibition of STAT3 signaling is considered as a crucial issue for the control of gastric carcinogenesis and invasion. Unfortunately, few drugs to directly inhibit STAT3 signaling have been introduced and clinically tried in gastric cancer patients. We have investigated the indirect pathway to inactivate STAT3 signaling via dephosphorylation, and focused on the role of SH2-containing protein tyrosine phosphatase 1 (SHP-1), which has not been extensively studied gastric cancer research field. We found that protein and gene expression of SHP-1 were minimal or abolished in gastric cancer cell lines, and transfection of SHP-1 plasmid in gastric cancer cells effectively downregulated phosphorylated STAT3 and inhibited cellular invasion and EMT. We also found that several agents including natural compounds enhanced SHP-1 expression in SHP-1-negative gastric cancer cells. Taken together, we suggest that SHP-1 is an important mediator to inactive STAT3 signaling in gastric cancer, and a discovery of effective compound which can induce SHP-1 expression might be valuable for an alternative therapeutic option of gastric cancer.

Original languageEnglish
Title of host publicationAdvances in Carcinogenesis Research
PublisherNova Science Publishers, Inc.
Pages55-74
Number of pages20
ISBN (Electronic)9781536104455
ISBN (Print)9781634858496
Publication statusPublished - 2016 Jan 1

Fingerprint

Protein Phosphatase 1
Protein Tyrosine Phosphatases
Stomach Neoplasms
Janus Kinase 2
STAT3 Transcription Factor
Epithelial-Mesenchymal Transition
Stomach
Cytotoxins
Metaplasia
Helicobacter pylori
Atrophy
Transfection
Immune System
Neoplasms
Carcinogenesis
Plasmids
Transcription Factors
Up-Regulation
Down-Regulation
Epithelial Cells

Keywords

  • Gastric cancer
  • SHP-1
  • STAT3

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Joo, M. K., & Park, J. J. (2016). Alternative way to inhibit STAT3 signaling in gastric cancer. In Advances in Carcinogenesis Research (pp. 55-74). Nova Science Publishers, Inc..

Alternative way to inhibit STAT3 signaling in gastric cancer. / Joo, Moon Kyung; Park, Jong Jae.

Advances in Carcinogenesis Research. Nova Science Publishers, Inc., 2016. p. 55-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

Joo, MK & Park, JJ 2016, Alternative way to inhibit STAT3 signaling in gastric cancer. in Advances in Carcinogenesis Research. Nova Science Publishers, Inc., pp. 55-74.
Joo MK, Park JJ. Alternative way to inhibit STAT3 signaling in gastric cancer. In Advances in Carcinogenesis Research. Nova Science Publishers, Inc. 2016. p. 55-74
Joo, Moon Kyung ; Park, Jong Jae. / Alternative way to inhibit STAT3 signaling in gastric cancer. Advances in Carcinogenesis Research. Nova Science Publishers, Inc., 2016. pp. 55-74
@inbook{e539e6b400624c3ab5b3df723f66efa9,
title = "Alternative way to inhibit STAT3 signaling in gastric cancer",
abstract = "The biologic impact of janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) axis in gastric cancer has been well established. Phosphorylated STAT3 dimerize and act as a transcription factor to upregulate various target genes involving tumor invasion and epithelial-mesenchymal transition (EMT). Furthermore, JAK2/STAT3 signaling mediates core interaction between cancer cells and microenvironmental immune system. For example, activated STAT3 in gastric epithelial cells by Helicobacter pylori (H. pylori)-induced cytotoxin-associated antigen (CagA) modulates differentiation of Thelper (Th)-17 lineage to promote chronic mucosal inflammation, atrophy and intestinal metaplasia. Thus, inhibition of STAT3 signaling is considered as a crucial issue for the control of gastric carcinogenesis and invasion. Unfortunately, few drugs to directly inhibit STAT3 signaling have been introduced and clinically tried in gastric cancer patients. We have investigated the indirect pathway to inactivate STAT3 signaling via dephosphorylation, and focused on the role of SH2-containing protein tyrosine phosphatase 1 (SHP-1), which has not been extensively studied gastric cancer research field. We found that protein and gene expression of SHP-1 were minimal or abolished in gastric cancer cell lines, and transfection of SHP-1 plasmid in gastric cancer cells effectively downregulated phosphorylated STAT3 and inhibited cellular invasion and EMT. We also found that several agents including natural compounds enhanced SHP-1 expression in SHP-1-negative gastric cancer cells. Taken together, we suggest that SHP-1 is an important mediator to inactive STAT3 signaling in gastric cancer, and a discovery of effective compound which can induce SHP-1 expression might be valuable for an alternative therapeutic option of gastric cancer.",
keywords = "Gastric cancer, SHP-1, STAT3",
author = "Joo, {Moon Kyung} and Park, {Jong Jae}",
year = "2016",
month = "1",
day = "1",
language = "English",
isbn = "9781634858496",
pages = "55--74",
booktitle = "Advances in Carcinogenesis Research",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Alternative way to inhibit STAT3 signaling in gastric cancer

AU - Joo, Moon Kyung

AU - Park, Jong Jae

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The biologic impact of janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) axis in gastric cancer has been well established. Phosphorylated STAT3 dimerize and act as a transcription factor to upregulate various target genes involving tumor invasion and epithelial-mesenchymal transition (EMT). Furthermore, JAK2/STAT3 signaling mediates core interaction between cancer cells and microenvironmental immune system. For example, activated STAT3 in gastric epithelial cells by Helicobacter pylori (H. pylori)-induced cytotoxin-associated antigen (CagA) modulates differentiation of Thelper (Th)-17 lineage to promote chronic mucosal inflammation, atrophy and intestinal metaplasia. Thus, inhibition of STAT3 signaling is considered as a crucial issue for the control of gastric carcinogenesis and invasion. Unfortunately, few drugs to directly inhibit STAT3 signaling have been introduced and clinically tried in gastric cancer patients. We have investigated the indirect pathway to inactivate STAT3 signaling via dephosphorylation, and focused on the role of SH2-containing protein tyrosine phosphatase 1 (SHP-1), which has not been extensively studied gastric cancer research field. We found that protein and gene expression of SHP-1 were minimal or abolished in gastric cancer cell lines, and transfection of SHP-1 plasmid in gastric cancer cells effectively downregulated phosphorylated STAT3 and inhibited cellular invasion and EMT. We also found that several agents including natural compounds enhanced SHP-1 expression in SHP-1-negative gastric cancer cells. Taken together, we suggest that SHP-1 is an important mediator to inactive STAT3 signaling in gastric cancer, and a discovery of effective compound which can induce SHP-1 expression might be valuable for an alternative therapeutic option of gastric cancer.

AB - The biologic impact of janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) axis in gastric cancer has been well established. Phosphorylated STAT3 dimerize and act as a transcription factor to upregulate various target genes involving tumor invasion and epithelial-mesenchymal transition (EMT). Furthermore, JAK2/STAT3 signaling mediates core interaction between cancer cells and microenvironmental immune system. For example, activated STAT3 in gastric epithelial cells by Helicobacter pylori (H. pylori)-induced cytotoxin-associated antigen (CagA) modulates differentiation of Thelper (Th)-17 lineage to promote chronic mucosal inflammation, atrophy and intestinal metaplasia. Thus, inhibition of STAT3 signaling is considered as a crucial issue for the control of gastric carcinogenesis and invasion. Unfortunately, few drugs to directly inhibit STAT3 signaling have been introduced and clinically tried in gastric cancer patients. We have investigated the indirect pathway to inactivate STAT3 signaling via dephosphorylation, and focused on the role of SH2-containing protein tyrosine phosphatase 1 (SHP-1), which has not been extensively studied gastric cancer research field. We found that protein and gene expression of SHP-1 were minimal or abolished in gastric cancer cell lines, and transfection of SHP-1 plasmid in gastric cancer cells effectively downregulated phosphorylated STAT3 and inhibited cellular invasion and EMT. We also found that several agents including natural compounds enhanced SHP-1 expression in SHP-1-negative gastric cancer cells. Taken together, we suggest that SHP-1 is an important mediator to inactive STAT3 signaling in gastric cancer, and a discovery of effective compound which can induce SHP-1 expression might be valuable for an alternative therapeutic option of gastric cancer.

KW - Gastric cancer

KW - SHP-1

KW - STAT3

UR - http://www.scopus.com/inward/record.url?scp=85029929211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029929211&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85029929211

SN - 9781634858496

SP - 55

EP - 74

BT - Advances in Carcinogenesis Research

PB - Nova Science Publishers, Inc.

ER -